Skip to main content
OpenTrials

Clinical trial condition

Duchenne Muscular Dystrophy

Explore clinical trials studying Duchenne Muscular Dystrophy. Study availability and eligibility vary by location and protocol.

214 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Duchenne Muscular Dystrophy trial results

Active, Not Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

NCT05881408

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • University of California at Davis Medical Center Sacramento, California, United States
  • Rady Children's Hospital-San Diego San Diego, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

NCT06450639

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Fractures, Bone, +13 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Children's Healthcare of Atlanta Center for Advanced Pediatrics Atlanta, Georgia, United States
  • Corewell Health Grand Rapids, Michigan, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

NCT06128564

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Chr de La Citadelle Liège, Belgium
  • Hôpital Necker-Enfants Malades Paris, France
  • Universitätsklinikum Essen Essen, Germany
  • PU A. Gemelli, Università Cattolica del Sacro Cuore Rome, Lazio, Italy
View Trial Details
Active, Not Recruiting

A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy

NCT06713135

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • UZ Gent (Universitair Ziekenhuis Gent) Ghent, Belgium
  • UZ Leuven (Universitair Ziekenhuis Leuven) Leuven, Belgium
  • University Hospital Brno Brno, Czechia
  • Fakultni Nemocnice Motol Prague, Czechia
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)

NCT05540860

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy

NCT06100887

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Open-label Extension of the HOPE-2 Trial

NCT04428476

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • University of California, Davis Sacramento, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Washington University St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）

NCT04587908

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Fukuoka, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Osaka, Japan
View Trial Details

Related conditions